GlobeNewswire

Stratfor Launches Threat Lens 2.0 To Expand Corporate Insight Into Global Security Trends

Dela

Company to showcase platform innovations, including a customizable risk dashboard and real-time threat monitoring, at ASIS Europe 2018

 

AUSTIN, Texas, April 12, 2018 (GLOBE NEWSWIRE) -- Stratfor, the world's leading geopolitical intelligence platform, announced the launch of Threat Lens 2.0 to dramatically expand the global situational awareness of corporate security teams charged with ensuring the security of people, assets and other interests around the world. As the company's premier protective intelligence solution for globally engaged organizations, this latest release of Stratfor Threat Lens TM continues to help leaders better identify, anticipate, measure and mitigate risks that emerging threats pose to their operations. The latest Threat Lens platform enhancements and new features will be available for one-on-one demonstrations April 18-20 during ASIS Europe 2018 in Rotterdam, Netherlands.

"The response has been overwhelmingly positive since the launch of Stratfor Threat Lens and now, thanks to direct engagement and collaboration with our corporate security clients, we're excited to make this significant investment and build upon the value Threat Lens offers," said Stratfor President Chip Harmon. "This next generation Threat Lens platform delivers the customization, immediacy and the practical security context necessary for leaders of today's global enterprises to focus on what's most important to their organizations and make decisions with confidence."

New additions included in the launch of Threat Lens 2.0, Stratfor's award winning protective intelligence solution for global organizations, include:

  • A customizable Risk Dashboard, enabling clients to monitor the rise and fall of threat environment trends within a country of interest, coupled with the most recent intelligence threat updates.
  • A new Threat Monitoring map interface that highlights the locations and types of threats as they develop in real-time to enhance global situational awareness.
  • Significantly expanding the global reach and frequency of Intelligence Updates with immediate access to insight on emerging items of interest so corporate security teams can stay ahead of the news cycle and inform decision makers.

"For organizations with the responsibility to better protect their people and assets around the world, today's security professionals need to be proactive and constantly ahead of the curve so they can anticipate threats before they materialize," said Stratfor Vice President of Tactical Analysis Scott Stewart who will be presenting on Risk Mitigation and the Importance of Howat ASIS Europe on April 19. "Enhancements such as the customizable risk dashboard and new threat monitoring indices, that highlight the directionality of specific threat trends by country, give today's security professionals the edge they need."

Additional product advancements include a redesign of the global threat map to enable better access to Stratfor Threat Lens' in-depth analyses, the ability to personalize the user experience with custom options and more prominent alerts when incidents occur within a client's areas of interest. The upcoming Threat Lens API release will also enable even greater integration of Threat Lens analysis, alerts and other updates into existing client systems to allow faster, better informed responses to developing threats around the globe.

Corporate security teams and organizations with interests around the world rely on Stratfor Threat Lens to pinpoint which evolving global events are truly significant and it remains the only unified solution that integrates the full spectrum of security issues they face, spanning threats against people, infrastructure, intellectual property and business continuity. Advancements and expanded features included in the launch of Threat Lens 2.0 build upon the multi-layered analytical framework that has consistently and effectively allowed Stratfor analysts to evaluate the immediate significance and future implications of evolving situations so clients can anticipate threats and implement protective measures.

Stratfor analysts will demonstrate the latest developments with Threat Lens 2.0 at ASIS Europe (Booth A5) in Rotterdam, April 18-20. Corporate security leaders and others seeking to identify, anticipate, measure and mitigate risks that emerging threats pose to their people, assets and interests around the world can also learn more at Stratfor.com/threatlens.

About Stratfor
As the world's leading geopolitical intelligence platform,  Stratfor  brings global events into valuable perspective, empowering businesses, governments and individuals to more confidently navigate their way through an increasingly complex international environment.  Stratfor Threat Lens TM , a customizable, protective intelligence solution, helps corporate security leaders identify, anticipate, measure and mitigate risks that emerging threats pose to their people, assets and interests around the world. Learn more at  Stratfor.com .

Media Contact

Joshua Cook
Stratfor Director of Public Relations
512-744-4309
pr@stratfor.com

A photo accompanying this announcement is available at http://resource.globenewswire.com/Resource/Download/417d60ef-4fd2-426b-a07a-dc2f24a2caf3




This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Stratfor Enterprises, LLC via Globenewswire

Om

GlobeNewswire



Följ GlobeNewswire

Abonnera på våra pressmeddelanden.

Senaste pressmeddelandena från GlobeNewswire

Arcoma AB: Arcoma presenterar på Redeye Life Science Day den 21:a november16.11.2018 12:53Pressmeddelande

16 November Den 21 november presenterar Jesper Söderqvist, VD på Arcoma, den senaste utvecklingen i Arcoma på Haymarket by Scandic i Stockholm. Presentationen "Arcoma, ett tillväxtbolag i en växande marknad" hålls klockan 13:00 och kan följas i livesändning på redeye.se/live/lsday-2018. Presentationen kommer även i efterhand att finnas tillgänglig på www.redeye.se/live/ls-day-2018 samt på Bolagets sida i Redeye Universe (redeye.se/company/Arcoma) Om Arcoma Arcoma, med lång erfarenhet av branschen, är en ledande leverantör av integrerade digitala röntgensystem med hög kvalitet och avancerad teknik. Arcomas produkter erbjuder den senaste digitala bildtekniken kombinerat med tekniskt avancerade rörliga positioneringssystem, vilket tillsammans med ergonomisk skandinavisk design, erbjuder kunden kompletta, konfigurerbara och funktionella digitala röntgensystem. Bolagets produkter säljs via återförsäljare samt via OEM-kunder och det finns idag över 3 500 av Arcomas röntgensystem installerade

Iconovo: kundprojekt blir framflyttat tre till sex månader8.11.2018 15:45Pressmeddelande

Fortsatt arbete med ett av Iconovos pågående kundprojekt kommer att flyttas fram tre till sex månader. Projektet avser utveckling av produkt anpassad för kund som ska svara för produktion och marknadslansering. Det aktuella arbetet var planerat att ske under fjärde kvartalet men beräknas ske under nästa år, och detta påverkar Iconovos omsättning under 2018 negativt med cirka 2 miljoner kronor. Orsaken är att kunden har beslutat att genomföra en mindre klinisk studie för att verifiera produkten innan nästa steg tas vilken omfattar investeringar i betydande mångmiljonbelopp i produktionskapacitet, baserat på Iconovos utveckling. Studien görs för kundens egna räkning och är inte villkorad av tillsynsmyndigheter. "Detta påverkar vårt resultat på kort sikt, men det faktum att kunden har beslutat att göra en betydande investering i faktisk produktion betyder att vi med stor säkerhet kan se fram emot licensintäkter under en lång tidsrymd framöver i samband med att produkten lanseras på markna

Stillfront Group AB: Inbjudan till Stillfront Groups kvartalsrapport för tredje kvartalet 20187.11.2018 14:34Pressmeddelande

PRESSMEDDELANDE 7 november 2018 Inbjudan till Stillfront Groups kvartalsrapport för tredje kvartalet 2018 Stillfront Groups kvartalsrapport för det tredje kvartalet 2018 kommer att publiceras klockan 07.00 den 22 november 2018. En webbsänd telefonkonferens kommer att hållas klockan 10.00 samma dag där Jörgen Larsson, VD och Sten Wranne, CFO, kommenterar resultatet. Presentationen och rapporten kommer efter presentationen att finnas tillgänglig på www.stillfront.com Webbsändningen nås på adressen: https://tv.streamfabriken.com/stillfront-q3-2018 För att delta via telefon, vänligen ring: SE: +46 8 566 426 63 UK: +44 20 300 898 01 US: +1 8 557 532 235 FÖR YTTERLIGARE INFORMATION, VÄNLIGEN KONTAKTA: Sofia Wretman, IR Phone: +46 708 11 64 30 sofia@stillfront.com OM STILLFRONT Stillfront är en oberoende utvecklare, förläggare och distributör av digitala spel - med visionen att bli en ledande indie-spelutvecklare och förläggare. Stillfront är verksamt genom tio näst intill självständiga dotte

Stillfront Group AB: Invitation to Stillfront Group Q3 presentation7.11.2018 14:34Pressmeddelande

Invitation to Stillfront Group Q3 presentation Stillfront Group interim report for the third quarter 2018 will be published at 07.00 CET on 22 November 2018. A presentation of the report will be held the same day at 10.00 CET via telephone conference or audiocast where Jörgen Larsson, CEO and CFO Sten Wranne are to comment on the report. The presentation can be viewed live at https://tv.streamfabriken.com/stillfront-q3-2018 To participate via phone please call: SE: +46 8 566 426 63 UK: +44 20 300 898 01 US: +1 8 557 532 235 FOR FURTHER INFORMATION, PLEASE CONTACT: Sofia Wretman, IR Phone: +46 708 11 64 30 sofia@stillfront.com ABOUT STILLFRONT Stillfront is a group of independent creators, publishers and distributors of digital games - with a vision to become the leading group of indie game creators and publishers. Stillfront operates through ten near-autonomous subsidiaries: Bytro Labs in Germany, Coldwood Interactive in Sweden, Power Challenge in the UK and Sweden, Dorado Online Games

Modus Therapeutics announces FDA Acceptance of Sevuparin IND for the treatment of sickle cell disease7.11.2018 08:30Pressmeddelande

STOCKHOLM, November 7, 2018. Karolinska Development's portfolio company Modus Therapeutics announces today that the U.S Food & Drug Administration (FDA) has approved the company's Investigational New Drug (IND) application to initiate a Phase I clinical trial with subcutaneous sevuparin for the treatment of sickle cell disease (SCD) FDA has decided to accept Modus Therapeutics' IND application of sevuparin for the treatment of SCD. Sevuparin is an innovative, proprietary modified polysaccharide drug with anti-adhesive, anti-aggregate and anti-inflammatory effects due to its multimodal mechanism of action. It has the potential to restore blood flow and prevent further microvascular obstructions in children and adults with SCD. At present, sevuparin is being evaluated as an intravenous infusion in a Phase II study in SCD patients with ongoing painful crises (also called vaso occlusive crises, VOC). In order to broaden the clinical scope and utility of sevuparin in the treatment of SCD, t

Modus Therapeutics announces FDA Acceptance of Sevuparin IND for the treatment of sickle cell disease7.11.2018 08:30Pressmeddelande

STOCKHOLM, November 7, 2018. Karolinska Development's portfolio company Modus Therapeutics announces today that the U.S Food & Drug Administration (FDA) has approved the company's Investigational New Drug (IND) application to initiate a Phase I clinical trial with subcutaneous sevuparin for the treatment of sickle cell disease (SCD) FDA has decided to accept Modus Therapeutics' IND application of sevuparin for the treatment of SCD. Sevuparin is an innovative, proprietary modified polysaccharide drug with anti-adhesive, anti-aggregate and anti-inflammatory effects due to its multimodal mechanism of action. It has the potential to restore blood flow and prevent further microvascular obstructions in children and adults with SCD. At present, sevuparin is being evaluated as an intravenous infusion in a Phase II study in SCD patients with ongoing painful crises (also called vaso occlusive crises, VOC). In order to broaden the clinical scope and utility of sevuparin in the treatment of SCD, t

I vårt pressrum kan du läsa de senaste pressmeddelandena, få tillgång till pressmaterial och hitta kontaktinformation.

Besök vårt pressrum